Apr 23, 2025 / 08:30PM GMT
Operator
Greetings, and welcome to the Q3 fiscal year 2025 ResMed earnings conference call. My name is Kevin, and I'll be your operator for today's call. (Operator Instructions) And also, please note this conference call is being recorded. (Operator Instructions) Let me hand the call over to ResMed's Chairman and CEO, Mick Farrell; for a brief introduction of Sally Schwartz, who recently joined the company as Chief Investor Relations Officer. Mick, please go ahead.
Michael Farrell - Resmed Inc - Chairman of the Board, Chief Executive Officer
Thank you, Kevin. I'm very excited to have Sally join the ResMed team, our newest ResMedian. She joined us earlier this week and brings more than two decades of experience across capital markets, health care and technology.
We look forward to Sally helping us to take Investor Relations to the next level here at ResMed, providing clarity, transparency and long-term alignment amongst current and future investors and all of our stakeholders. So Salli, we're thrilled to have you on board.
Salli Schwartz
Q3 2025 Resmed Inc Earnings Call Transcript
Apr 24, 2025
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers